These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1380423)

  • 1. CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.
    Neil GA; Summers RW; Cheyne BA; Capenter C; Huang WL; Kansas GS; Waldschmidt TJ
    Dig Dis Sci; 1992 Sep; 37(9):1390-5. PubMed ID: 1380423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease.
    Yacyshyn BR; Pilarski LM
    Gut; 1993 Dec; 34(12):1698-704. PubMed ID: 7506695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability.
    Yacyshyn BR; Meddings JB
    Gastroenterology; 1995 Jan; 108(1):132-7. PubMed ID: 7528696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.
    Yacyshyn BR; Lazarovits A; Tsai V; Matejko K
    Gastroenterology; 1994 Nov; 107(5):1364-71. PubMed ID: 7523224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
    Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
    J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
    Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
    Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B1a Lymphocytes (CD19+CD5+) Deficiency in Patients with Crohn's Disease and Its Relation with Disease Severity.
    Gil-Borras R; García-Ballesteros C; Benet-Campos C; Catalán-Serra I; López-Chuliá F; Cuéllar C; Andreu-Ballester JC
    Dig Dis; 2018; 36(3):194-201. PubMed ID: 29421816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease.
    Sampalo A; López-Gómez M; Jiménez-Alonso J; Ortiz F; Samaniego F; Garrido F
    Clin Immunol Immunopathol; 1993 Mar; 66(3):260-8. PubMed ID: 7679344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the expression of CD5 by human B cells and correlation with functional activity.
    Vernino LA; Pisetsky DS; Lipsky PE
    Cell Immunol; 1992 Jan; 139(1):185-97. PubMed ID: 1370255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte subsets in inflammatory bowel disease: peripheral blood.
    Selby WS; Jewell DP
    Gut; 1983 Feb; 24(2):99-105. PubMed ID: 6221976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating lymphocyte subpopulations in patients with Crohn's disease].
    Sauer D; Sauer H; Fiebig H
    Gastroenterol J; 1991; 51(1):27-32. PubMed ID: 1910492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes.
    Auer IO; Götz S; Ziemer E; Malchow H; Ehms H
    Gut; 1979 Apr; 20(4):261-8. PubMed ID: 312753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.
    Vuillier F; Scott-Algara D; Tortevoye P; Pialoux G; Dighiero G
    Clin Exp Immunol; 1991 Sep; 85(3):476-80. PubMed ID: 1716542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in immunoregulatory CD5+ B cells precede the diagnosis of multiple myeloma.
    Paglieroni T; MacKenzie MR; Caggiano V
    Ann N Y Acad Sci; 1992 May; 651():486-7. PubMed ID: 1376067
    [No Abstract]   [Full Text] [Related]  

  • 15. B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis.
    Mix E; Olsson T; Correale J; Baig S; Kostulas V; Olsson O; Link H
    Clin Exp Immunol; 1990 Jan; 79(1):21-7. PubMed ID: 1689227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome.
    Jamin C; Lamour A; Pennec YL; Hirn M; Le Goff P; Youinou P
    Clin Exp Immunol; 1993 May; 92(2):245-50. PubMed ID: 7683586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study.
    Lynch EF; Jones PA; Swerdlow SH
    Cytometry; 1995 Sep; 22(3):223-31. PubMed ID: 8556954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of peripheral blood CD5+ B cells in inflammatory bowel disease.
    Mishima Y; Ishihara S; Amano Y; Oshima N; Kadota C; Otani A; Moriyama I; Li YY; Aziz MM; Kinoshita Y
    Scand J Gastroenterol; 2009; 44(2):172-9. PubMed ID: 18830898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells.
    Punnonen J; Aversa GG; Vandekerckhove B; Roncarolo MG; de Vries JE
    J Immunol; 1992 Jun; 148(11):3398-404. PubMed ID: 1375243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
    Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
    Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.